Skip to main content

Global Selector
Newsroom
Partnering
Contact

We Are CSL
We Are CSL
Our Businesses and Products
Vita: Original Stories
Our Leadership
Worldwide Locations
Corporate Governance
Our Impact
Frequently Asked Questions (FAQs)
Our Businesses and Products
CSL Behring
CSL Seqirus
CSL Vifor
Corporate Governance
Code of Conduct
Core Policies
Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.
Read the Stories
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Learn more by visiting each section.
Our Businesses and Products
Patients & Public Health
Patients & Public Health
Rare & Serious Diseases
Iron Deficiency
Nephrology
Vaccines
Patient Support & Organizations
Rare & Serious Diseases
Immunodeficiency and Autoimmune Diseases
Hereditary Bleeding Disorders
Hereditary Angioedema
Alpha 1 Antitrypsin Deficiency
Iron Deficiency
Iron Deficiency Patient Stories
Nephrology
Nephrology Patient Stories
Vaccines
COVID-19
Pandemic Response
In-Licensing
Antivenoms and Q fever Vaccine
Patient Support & Organizations
CSL Behring USA Support & Assistance Programs
CSL Vifor Managed Access Programs
LEAD Grants
CSL Community Impact Awards
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
CSL Behring: Rare & Serious Diseases
Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers.
CSL Seqirus: Vaccines
R&D
R&D
R&D Capabilities
Awards, Grants and Initiatives
World-Class R&D Network
Product Pipeline
Clinical Studies at CSL
Partnering
Clinical Studies at CSL
Current Clinical Trials
Research Practices
How to Participate
Clinical Studies FAQs
R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.
R&D Capabilities
One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.
Awards, Grants and Initiatives
Sustainability
Careers
Careers
Explore Careers at CSL
Life at CSL
Benefits
Early Careers at CSL
Inclusion and Belonging
People Powering Science
Early Careers at CSL
Apprenticeships
Internships at CSL
Graduate Rotational Programs at CSL
At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out.
Read About Our Approach to Inclusion and Belonging
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
Early Careers at CSL
Investors

Search

We Are CSL
- Our Businesses and Products
- Corporate Governance
Patients & Public Health
- Rare & Serious Diseases
- Iron Deficiency
- Nephrology
- Vaccines
- Patient Support & Organizations
R&D
- Clinical Studies at CSL
Sustainability
Careers
- Early Careers at CSL
Global Selector

CSL
We Are CSL
Vita: Original Stories
2018
The Impact of Sickle Cell Disease

The Impact of Sickle Cell Disease

Why CSL Behring is exploring new treatment options for this rare disease.

By Greg Healy 29 Oct 2018

story

Topics

Get the latest stories from Vita by signing up for our newsletter.

share

Terms of Use Cookie Policy Global Privacy Policy Accessibility Statement Sitemap

Terms of Use
Cookie Policy
Global Privacy Policy
Accessibility Statement
Sitemap

CSL, All Rights Reserved © 2026

Video Modal - Coming Soon

Insider Email Validation - Coming Soon

Cookie Policy Banner - Coming Soon